Review
Open access
Aug 2026
Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review)
While p38 MAPK represents a promising therapeutic target for liver fibrosis, future research should focus on developing isoform-specific inhibitors, understanding context-dependent signaling outcomes, and designing combination therapies to enhance efficacy and minimize off-target effects.
Xueqin Yang, Hua-Rong Li, Hao-Sen Ye et al.
· International Journal of Mol... · 0 citations